JPMorgan raised Moderna's (MRNA) price target to $77 from $40 and Okta's (OKTA) to $165 from $120. HSBC raised NVIDIA's (NVDA) price target to $360 from $325. Morgan Stanley raised Ferguson's (FERG) price target to $295 from $290. Several other institutions also adjusted price targets for various U.S. companies.